The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-10

AUTHORS

A. M. Elsharkawy, F. Oakley, D. A. Mann

ABSTRACT

Liver fibrosis and its end-stage disease cirrhosis are major world health problems arising from chronic injury of the liver by a variety of etiological factors including viruses, alcohol and drug abuse, the metabolic syndrome, autoimmune disease and hereditary disorders of metabolism. Fibrosis is a progressive pathological process in which wound-healing myofibroblasts of the liver respond to injury by promoting replacement of the normal hepatic tissue with a scar-like matrix composed of cross-linked collagen. Until recently it was believed that this process was irreversible. However emerging experimental and clinical evidence is starting to show that even cirrhosis is potentially reversible. Key to this is the discovery that reversion of fibrosis is accompanied by clearance of hepatic stellate cells (HSC) by apoptosis. Furthermore, proof-of-concept studies in rodents have demonstrated that experimental augmentation of HSC apoptosis will promote the resolution of fibrosis. Consequently there is now considerable interest in determining the molecular events that regulate HSC apoptosis and the discovery of drugs that will stimulate HSC apoptosis in a selective manner. This review will consider the regulatory role played by growth factors (e.g. NGF, IGF-1, TGFβ), death receptor ligands (TRAIL, FAS), components and regulators of extracellular matrix (integrins, collagen, matrix metalloproteinases and their tissue inhibitors) and signal transduction proteins and transcription factors (Rho/Rho kinase, Jun N-terminal Kinase (JNK), IkappaKinase (IKK), NF-κ B). The potential for known pharmacological agents such as gliotoxin, sulfasalazine, benzodiazepine ligands, curcumin and tanshinone I to induce HSC apoptosis and therefore to be used therapeutically will be explored. More... »

PAGES

927-939

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10495-005-1055-4

DOI

http://dx.doi.org/10.1007/s10495-005-1055-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031741653

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16151628


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Curcumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extracellular Matrix", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gliotoxin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Growth Substances", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Cirrhosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MAP Kinase Signaling System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogen-Activated Protein Kinase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "N-Methyl-3,4-methylenedioxyamphetamine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "NF-kappa B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.123047.3", 
          "name": [
            "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elsharkawy", 
        "givenName": "A. M.", 
        "id": "sg:person.0615371546.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615371546.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.123047.3", 
          "name": [
            "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oakley", 
        "givenName": "F.", 
        "id": "sg:person.01330224315.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330224315.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.123047.3", 
          "name": [
            "Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mann", 
        "givenName": "D. A.", 
        "id": "sg:person.01361723223.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361723223.86"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1207558", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052108355", 
          "https://doi.org/10.1038/sj.onc.1207558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/labinvest.3700116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048677985", 
          "https://doi.org/10.1038/labinvest.3700116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb1093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049081004", 
          "https://doi.org/10.1038/ncb1093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207556", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006947464", 
          "https://doi.org/10.1038/sj.onc.1207556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019478799", 
          "https://doi.org/10.1038/sj.onc.1207523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1024792529601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004954307", 
          "https://doi.org/10.1023/a:1024792529601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000268283", 
          "https://doi.org/10.1038/sj.onc.1207522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni0302-221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045237056", 
          "https://doi.org/10.1038/ni0302-221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-5926-2-s1-s8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052392329", 
          "https://doi.org/10.1186/1476-5926-2-s1-s8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/364806a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050650199", 
          "https://doi.org/10.1038/364806a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1203239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046798251", 
          "https://doi.org/10.1038/sj.onc.1203239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207532", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046384652", 
          "https://doi.org/10.1038/sj.onc.1207532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006188141", 
          "https://doi.org/10.1038/sj.onc.1207513"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-10", 
    "datePublishedReg": "2005-10-01", 
    "description": "Liver fibrosis and its end-stage disease cirrhosis are major world health problems arising from chronic injury of the liver by a variety of etiological factors including viruses, alcohol and drug abuse, the metabolic syndrome, autoimmune disease and hereditary disorders of metabolism. Fibrosis is a progressive pathological process in which wound-healing myofibroblasts of the liver respond to injury by promoting replacement of the normal hepatic tissue with a scar-like matrix composed of cross-linked collagen. Until recently it was believed that this process was irreversible. However emerging experimental and clinical evidence is starting to show that even cirrhosis is potentially reversible. Key to this is the discovery that reversion of fibrosis is accompanied by clearance of hepatic stellate cells (HSC) by apoptosis. Furthermore, proof-of-concept studies in rodents have demonstrated that experimental augmentation of HSC apoptosis will promote the resolution of fibrosis. Consequently there is now considerable interest in determining the molecular events that regulate HSC apoptosis and the discovery of drugs that will stimulate HSC apoptosis in a selective manner. This review will consider the regulatory role played by growth factors (e.g. NGF, IGF-1, TGF\u03b2), death receptor ligands (TRAIL, FAS), components and regulators of extracellular matrix (integrins, collagen, matrix metalloproteinases and their tissue inhibitors) and signal transduction proteins and transcription factors (Rho/Rho kinase, Jun N-terminal Kinase (JNK), IkappaKinase (IKK), NF-\u03ba B). The potential for known pharmacological agents such as gliotoxin, sulfasalazine, benzodiazepine ligands, curcumin and tanshinone I to induce HSC apoptosis and therefore to be used therapeutically will be explored.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10495-005-1055-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1117236", 
        "issn": [
          "1360-8185", 
          "1573-675X"
        ], 
        "name": "Apoptosis", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "hepatic stellate cells", 
      "HSC apoptosis", 
      "liver fibrosis", 
      "major world health problem", 
      "reversion of fibrosis", 
      "progressive pathological process", 
      "hepatic stellate cell apoptosis", 
      "resolution of fibrosis", 
      "normal hepatic tissue", 
      "world health problem", 
      "stellate cell apoptosis", 
      "metabolic syndrome", 
      "clinical evidence", 
      "chronic injury", 
      "autoimmune diseases", 
      "etiological factors", 
      "stellate cells", 
      "pharmacological agents", 
      "health problems", 
      "fibrosis", 
      "hepatic tissue", 
      "cross-linked collagen", 
      "benzodiazepine ligands", 
      "discovery of drugs", 
      "death receptor ligands", 
      "hereditary disorder", 
      "drug abuse", 
      "growth factor", 
      "cell apoptosis", 
      "pathological processes", 
      "receptor ligands", 
      "cirrhosis", 
      "apoptosis", 
      "injury", 
      "liver", 
      "concept study", 
      "molecular events", 
      "tanshinone I", 
      "regulatory role", 
      "extracellular matrix", 
      "sulfasalazine", 
      "syndrome", 
      "transcription factors", 
      "factors", 
      "myofibroblasts", 
      "disease", 
      "clearance", 
      "disorders", 
      "drugs", 
      "virus", 
      "experimental augmentation", 
      "rodents", 
      "curcumin", 
      "tissue", 
      "role", 
      "metabolism", 
      "abuse", 
      "augmentation", 
      "collagen", 
      "cells", 
      "gliotoxin", 
      "review", 
      "signal transduction proteins", 
      "agents", 
      "transduction proteins", 
      "selective manner", 
      "evidence", 
      "replacement", 
      "study", 
      "protein", 
      "regulation", 
      "alcohol", 
      "discovery", 
      "considerable interest", 
      "regulator", 
      "reversal", 
      "events", 
      "ligands", 
      "manner", 
      "reversion", 
      "potential", 
      "variety", 
      "components", 
      "interest", 
      "process", 
      "resolution", 
      "problem", 
      "proof", 
      "matrix"
    ], 
    "name": "The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis", 
    "pagination": "927-939", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031741653"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10495-005-1055-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16151628"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10495-005-1055-4", 
      "https://app.dimensions.ai/details/publication/pub.1031741653"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_406.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10495-005-1055-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-1055-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-1055-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-1055-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-1055-4'


 

This table displays all metadata directly associated to this object as RDF triples.

277 TRIPLES      22 PREDICATES      144 URIs      123 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10495-005-1055-4 schema:about N148e087042c54f6d9657c2d23f1c8dca
2 N18380769090541828f7912e5a4e35283
3 N196111c2a31042ac946fb08208bda8f7
4 N464c9753ee9b4f41b864547924da3bfe
5 N4e40262c7c3942d9972740e7ba92b12f
6 N4ff1aa8bfd5a409b86f436078e899f32
7 N6abe40c182014db2a3f9f7ca506c51a9
8 N71e3333ecb4741eea5f7661f81c825d8
9 N78b9d1e8d320403fb766e3d37458c37d
10 Na26398d71c0348ac9de9af4825a1d052
11 Na52138e4cf2c498e957be5b3e7bffeff
12 Nb504a6952eb4454cb25e2b4c6e14778b
13 Ncaf4aeb1c77847819fcfb08fd92b872a
14 Ndf4a7ee418dd411987a3af5433d1ea8c
15 Nfaac3d5a999a44269ce24def234eb10f
16 anzsrc-for:06
17 anzsrc-for:0601
18 schema:author N55359e0b37cd4ea5a7d11282a1c95499
19 schema:citation sg:pub.10.1023/a:1024792529601
20 sg:pub.10.1038/364806a0
21 sg:pub.10.1038/labinvest.3700116
22 sg:pub.10.1038/ncb1093
23 sg:pub.10.1038/ni0302-221
24 sg:pub.10.1038/sj.onc.1203239
25 sg:pub.10.1038/sj.onc.1207513
26 sg:pub.10.1038/sj.onc.1207522
27 sg:pub.10.1038/sj.onc.1207523
28 sg:pub.10.1038/sj.onc.1207532
29 sg:pub.10.1038/sj.onc.1207556
30 sg:pub.10.1038/sj.onc.1207558
31 sg:pub.10.1186/1476-5926-2-s1-s8
32 schema:datePublished 2005-10
33 schema:datePublishedReg 2005-10-01
34 schema:description Liver fibrosis and its end-stage disease cirrhosis are major world health problems arising from chronic injury of the liver by a variety of etiological factors including viruses, alcohol and drug abuse, the metabolic syndrome, autoimmune disease and hereditary disorders of metabolism. Fibrosis is a progressive pathological process in which wound-healing myofibroblasts of the liver respond to injury by promoting replacement of the normal hepatic tissue with a scar-like matrix composed of cross-linked collagen. Until recently it was believed that this process was irreversible. However emerging experimental and clinical evidence is starting to show that even cirrhosis is potentially reversible. Key to this is the discovery that reversion of fibrosis is accompanied by clearance of hepatic stellate cells (HSC) by apoptosis. Furthermore, proof-of-concept studies in rodents have demonstrated that experimental augmentation of HSC apoptosis will promote the resolution of fibrosis. Consequently there is now considerable interest in determining the molecular events that regulate HSC apoptosis and the discovery of drugs that will stimulate HSC apoptosis in a selective manner. This review will consider the regulatory role played by growth factors (e.g. NGF, IGF-1, TGFβ), death receptor ligands (TRAIL, FAS), components and regulators of extracellular matrix (integrins, collagen, matrix metalloproteinases and their tissue inhibitors) and signal transduction proteins and transcription factors (Rho/Rho kinase, Jun N-terminal Kinase (JNK), IkappaKinase (IKK), NF-κ B). The potential for known pharmacological agents such as gliotoxin, sulfasalazine, benzodiazepine ligands, curcumin and tanshinone I to induce HSC apoptosis and therefore to be used therapeutically will be explored.
35 schema:genre article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf N2bbb6446685a4f7082920361baad84fe
39 N6c07854f2e13478980439a354d8430e4
40 sg:journal.1117236
41 schema:keywords HSC apoptosis
42 abuse
43 agents
44 alcohol
45 apoptosis
46 augmentation
47 autoimmune diseases
48 benzodiazepine ligands
49 cell apoptosis
50 cells
51 chronic injury
52 cirrhosis
53 clearance
54 clinical evidence
55 collagen
56 components
57 concept study
58 considerable interest
59 cross-linked collagen
60 curcumin
61 death receptor ligands
62 discovery
63 discovery of drugs
64 disease
65 disorders
66 drug abuse
67 drugs
68 etiological factors
69 events
70 evidence
71 experimental augmentation
72 extracellular matrix
73 factors
74 fibrosis
75 gliotoxin
76 growth factor
77 health problems
78 hepatic stellate cell apoptosis
79 hepatic stellate cells
80 hepatic tissue
81 hereditary disorder
82 injury
83 interest
84 ligands
85 liver
86 liver fibrosis
87 major world health problem
88 manner
89 matrix
90 metabolic syndrome
91 metabolism
92 molecular events
93 myofibroblasts
94 normal hepatic tissue
95 pathological processes
96 pharmacological agents
97 potential
98 problem
99 process
100 progressive pathological process
101 proof
102 protein
103 receptor ligands
104 regulation
105 regulator
106 regulatory role
107 replacement
108 resolution
109 resolution of fibrosis
110 reversal
111 reversion
112 reversion of fibrosis
113 review
114 rodents
115 role
116 selective manner
117 signal transduction proteins
118 stellate cell apoptosis
119 stellate cells
120 study
121 sulfasalazine
122 syndrome
123 tanshinone I
124 tissue
125 transcription factors
126 transduction proteins
127 variety
128 virus
129 world health problem
130 schema:name The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
131 schema:pagination 927-939
132 schema:productId N6119b1d0a38f474986543827ec410cb5
133 N8c81a92812424798a033b6697f48aecb
134 Nc5b8394f71254aec96e416ee469fa09e
135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031741653
136 https://doi.org/10.1007/s10495-005-1055-4
137 schema:sdDatePublished 2022-06-01T22:05
138 schema:sdLicense https://scigraph.springernature.com/explorer/license/
139 schema:sdPublisher N22eef17fbae3488bbb8231ac5231e186
140 schema:url https://doi.org/10.1007/s10495-005-1055-4
141 sgo:license sg:explorer/license/
142 sgo:sdDataset articles
143 rdf:type schema:ScholarlyArticle
144 N148e087042c54f6d9657c2d23f1c8dca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Macrophages
146 rdf:type schema:DefinedTerm
147 N18380769090541828f7912e5a4e35283 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Mitogen-Activated Protein Kinase 3
149 rdf:type schema:DefinedTerm
150 N196111c2a31042ac946fb08208bda8f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Extracellular Matrix
152 rdf:type schema:DefinedTerm
153 N22eef17fbae3488bbb8231ac5231e186 schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 N2bbb6446685a4f7082920361baad84fe schema:volumeNumber 10
156 rdf:type schema:PublicationVolume
157 N464c9753ee9b4f41b864547924da3bfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Growth Substances
159 rdf:type schema:DefinedTerm
160 N4e40262c7c3942d9972740e7ba92b12f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Apoptosis
162 rdf:type schema:DefinedTerm
163 N4ff1aa8bfd5a409b86f436078e899f32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Liver
165 rdf:type schema:DefinedTerm
166 N55359e0b37cd4ea5a7d11282a1c95499 rdf:first sg:person.0615371546.52
167 rdf:rest Nf547805a3af54948b1f41e69455a1a8b
168 N6119b1d0a38f474986543827ec410cb5 schema:name doi
169 schema:value 10.1007/s10495-005-1055-4
170 rdf:type schema:PropertyValue
171 N6abe40c182014db2a3f9f7ca506c51a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Curcumin
173 rdf:type schema:DefinedTerm
174 N6c07854f2e13478980439a354d8430e4 schema:issueNumber 5
175 rdf:type schema:PublicationIssue
176 N71e3333ecb4741eea5f7661f81c825d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name N-Methyl-3,4-methylenedioxyamphetamine
178 rdf:type schema:DefinedTerm
179 N78b9d1e8d320403fb766e3d37458c37d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name NF-kappa B
181 rdf:type schema:DefinedTerm
182 N8c81a92812424798a033b6697f48aecb schema:name dimensions_id
183 schema:value pub.1031741653
184 rdf:type schema:PropertyValue
185 Na26398d71c0348ac9de9af4825a1d052 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Liver Cirrhosis
187 rdf:type schema:DefinedTerm
188 Na52138e4cf2c498e957be5b3e7bffeff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Gliotoxin
190 rdf:type schema:DefinedTerm
191 Nb504a6952eb4454cb25e2b4c6e14778b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Sirolimus
193 rdf:type schema:DefinedTerm
194 Nc5b8394f71254aec96e416ee469fa09e schema:name pubmed_id
195 schema:value 16151628
196 rdf:type schema:PropertyValue
197 Ncaf4aeb1c77847819fcfb08fd92b872a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name MAP Kinase Signaling System
199 rdf:type schema:DefinedTerm
200 Ndf4a7ee418dd411987a3af5433d1ea8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Animals
202 rdf:type schema:DefinedTerm
203 Nf235162676cb4ed2a64a7ba47e00e680 rdf:first sg:person.01361723223.86
204 rdf:rest rdf:nil
205 Nf547805a3af54948b1f41e69455a1a8b rdf:first sg:person.01330224315.54
206 rdf:rest Nf235162676cb4ed2a64a7ba47e00e680
207 Nfaac3d5a999a44269ce24def234eb10f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Humans
209 rdf:type schema:DefinedTerm
210 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
211 schema:name Biological Sciences
212 rdf:type schema:DefinedTerm
213 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
214 schema:name Biochemistry and Cell Biology
215 rdf:type schema:DefinedTerm
216 sg:journal.1117236 schema:issn 1360-8185
217 1573-675X
218 schema:name Apoptosis
219 schema:publisher Springer Nature
220 rdf:type schema:Periodical
221 sg:person.01330224315.54 schema:affiliation grid-institutes:grid.123047.3
222 schema:familyName Oakley
223 schema:givenName F.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330224315.54
225 rdf:type schema:Person
226 sg:person.01361723223.86 schema:affiliation grid-institutes:grid.123047.3
227 schema:familyName Mann
228 schema:givenName D. A.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361723223.86
230 rdf:type schema:Person
231 sg:person.0615371546.52 schema:affiliation grid-institutes:grid.123047.3
232 schema:familyName Elsharkawy
233 schema:givenName A. M.
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615371546.52
235 rdf:type schema:Person
236 sg:pub.10.1023/a:1024792529601 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004954307
237 https://doi.org/10.1023/a:1024792529601
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/364806a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050650199
240 https://doi.org/10.1038/364806a0
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/labinvest.3700116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048677985
243 https://doi.org/10.1038/labinvest.3700116
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/ncb1093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049081004
246 https://doi.org/10.1038/ncb1093
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/ni0302-221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045237056
249 https://doi.org/10.1038/ni0302-221
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/sj.onc.1203239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046798251
252 https://doi.org/10.1038/sj.onc.1203239
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/sj.onc.1207513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006188141
255 https://doi.org/10.1038/sj.onc.1207513
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/sj.onc.1207522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000268283
258 https://doi.org/10.1038/sj.onc.1207522
259 rdf:type schema:CreativeWork
260 sg:pub.10.1038/sj.onc.1207523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019478799
261 https://doi.org/10.1038/sj.onc.1207523
262 rdf:type schema:CreativeWork
263 sg:pub.10.1038/sj.onc.1207532 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046384652
264 https://doi.org/10.1038/sj.onc.1207532
265 rdf:type schema:CreativeWork
266 sg:pub.10.1038/sj.onc.1207556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006947464
267 https://doi.org/10.1038/sj.onc.1207556
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/sj.onc.1207558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052108355
270 https://doi.org/10.1038/sj.onc.1207558
271 rdf:type schema:CreativeWork
272 sg:pub.10.1186/1476-5926-2-s1-s8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052392329
273 https://doi.org/10.1186/1476-5926-2-s1-s8
274 rdf:type schema:CreativeWork
275 grid-institutes:grid.123047.3 schema:alternateName Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK
276 schema:name Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Level D, South Academic Block, SO16 6YD, Southampton, UK
277 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...